Hye-won Kim, Former Executive Director of CMS Lab, Appointed as New CEO of SD Biotechnologies
"Reorganizing the Brand Portfolio"
Dae Won Pharmaceutical announced on June 16 that it has appointed Hye-won Kim, former Executive Director at CMS Lab, as the new CEO of its subsidiary, SD Biotechnologies.
Kim, the newly appointed CEO, is a derma cosmetics expert who has worked for approximately 26 years at leading domestic beauty companies such as Amorepacific, Neopharm, and CMS Lab, gaining experience in planning, marketing, sales, and research work.
SD Biotechnologies plans to use Kim’s appointment as an opportunity to reorganize its brand portfolio, strengthen its product development and domestic and global retail sales capabilities, and thereby accelerate the growth of its cosmetics business sector.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Kim stated, “We will systematize the business structure through a multifaceted assessment of current distribution channels and a product-focused sales and marketing strategy. Leveraging my accumulated network in major original design manufacturing (ODM) and experience in designing new business circulation structures, I will focus on establishing a sustainable growth pipeline for SD Biotechnologies.”
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.